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therapies. In addition, the slight photo-
protective effect seen with commercial
creams containing idebenone may be
due to the sunscreen ingredients that
they contain. Idebenone specifically
does not increase the photoprotective
value of an established antioxidant
combination of Cþ Eþ ferulic acid.
The results of this study also validate
an earlier study showing that
Cþ Eþ ferulic acid offers eight-fold UV
photoprotection to skin (Lin et al., 2005).
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TO THE EDITOR
Atopic dermatitis (AD) is a chronic
relapsing inflammatory skin disease by
typically distributed eczematous skin
lesions with lichenification, pruritic
excoriation, and severe dry skin. During
the past year, there have been some
significant advances concerning our
understanding of the cellular and im-
munologic mechanisms that underlie
AD as well as the immunologic triggers
involved in its pathogenesis. Complex
interactions among a multitude of
genetic, environmental, skin barrier,
pharmacologic, and immunologic
factors contribute to the pathogenesis
of AD (Kay, 2001; Cookson, 2004;
Leung et al., 2004). In addition to the
epidermal differentiation complex on
chromosome 1q21, several candidate
genes located on different chromo-
somes have been introduced via link-
age analyses (MacLean and Eidelman,
2001; Bowcock and Cookson, 2004).
The recent development of gene
knockout and transgenic mouse models
may contribute to developing effective
drugs and to elucidating AD’s associated
factors (Heinzmann and Daser, 2002).
The techniques used in proteomics and
genomics have allowed researchers to
understand many diseases and disease-
associated factors regardless of their
drawbacks (Banks et al., 2000; de Hoog
and Mann, 2004; Kramer and Cohen,
2004). Several techniques to identify the
differentially expressed genes have been
established, such as differential display
PCR, representational difference analy-
sis, cDNA microarray, serial analysis
gene expression and suppression sub-
tractive hybridization. To gain under-
standing on the biological implication of
AD, we first explored specific genes by
performing SSH and then chose several
genes from these data to performe real-
time RT-PCR.Abbreviations: AD, atopic dermatitis; SSH, suppression subtractive hybridization
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The AD samples were collected from
nonasthmatic atopic patients according
to our previous reports (Jeong et al.,
2003; Park et al., 2004). The nonatopic
control samples were selected and
taken from the foreskins and skin from
plastic surgery of adults who did not
have a personal/family history or any
sign of AD. None of the subjects had
received systemic or topical corticos-
teroids, or immunomodulators for at
least 2 weeks prior to the study. As a
criterion for AD patients, we checked
the serum IgE levels. The serum IgE
levels of all 22 AD patients were from
250 to over 20,000 IU/ml by the Cap
system (Pharmacia Biotech, Bucking-
ham, UK, Average 3,700 IU). All the
patients showed a positive prick test to
dust and mites. Prior to performing the
subtraction library construction, we
checked the IL-4 expression levels in
the AD skin tissues. The IL-4 mRNA
levels were expressed in all AD sam-
ples, but this was not detected in the
normal samples (data not shown). The
mean SCORAD (SCORing Atopic
Dermatitis) indexes of AD for SSH
(8 patients) and real-time PCR (14
patients) were 45.7713.4 and 53.67
17.6. Punch biopsies 5 mm in diameter
were individually obtained from the
lesional skin in the posterior thigh or
lower back of AD and psoriasis pa-
tients. The medical ethical committee
of the Samsung Biomedical Research
Institute approved all described studies.
This study was conducted according to
the Declaration of Helsinki Principles
and written informed consent obtained
from all participants.
For the SSH, we used one normal
control and eight AD samples. The
cDNAs were synthesized from 2mg of
total RNA by using a Super SMART PCR
cDNA kit and the SSH was performed
with a CLONTEC PCR-Select cDNA
Subtraction kit (BD Bioscience, Palo
Alto, CA) according to the manufac-
turer’s protocol. Approximately 1,000
clones from the SSH library were
arrayed in duplicate by spotting them
onto nylon membranes, and they were
screened by reverse Northern blotting
using the subtracted cDNA probes.
After sequencing and the database
searches, the genes could be divided
into two groups: those with known
functions and those with unknown
functions. We found 450 different
genes, and then excluded the unidenti-
fied and ribosomal genes and, finally,
we selected 134 genes (http://
www.sdgrc.re.kr/). Most of the genes
with known functions could be classi-
fied into 12 groups based on their
functions. To support and complement
the result of SSH screening, five genes
were selected to confirm their expres-
sion levels. We used real-time RT-PCR
to check their expression levels among
AD patients, psoriasis patients, and
normal control subjects. We recruited
10 psoriasis patients with typical skin
lesions who had not received any
treatment for at least 2 weeks and also
used 10 normal control samples. Five
genes of special interest, such as sphin-
gosine-1-phosphate lyase, cathepsin B,
coxsackie virus and adenovirus receptor,
prolyl endopeptidase and delta sleep
inducing peptide were selected for their
potential functionality with AD as based
on the references search (Table 1).
As the AD patients have a reduced
skin barrier function and dry skin, and
sphingosine-1-phosphate lyase, which
are related to lipid metabolism, they
Table 1. List of genes subjected into real-time RT-PCR
Gene name Function Accession no.
Sphingosine-1-phosphate lyase 1 (SPL) Lipid metabolism BC052991
Proline endopeptidase (PREP) Proteolysis NM_002726
Cathepsin B (CTSB) Immunoregulatory and
inflammatory process
NM_004887
Coxsackie virus and adenovirus
receptor (CXADR)
Virus receptor AF242865
Delta sleep-inducing peptide,
immunoreactor (DSIP)
Immunoregulatory and
inflammatory process
BC018148
10.0
7.5
5.0
2.5
SPL DSIP
PREP CXARD
CTSB
0.0
Normal
1.64±0.37 7.54±2.01 0.48±0.18
Atopic
dermatitis
Psoriasis Normal
0.92±0.17 3.68±1.29 0.16±0.02
Atopic
dermatitis
Psoriasis
Normal
1.3±0.29 2.15±0.85 1.05±0.34
Atopic
dermatitis
PsoriasisNormal
1.23±0.49 3.29±0.89 0.35±0.14
Atopic
dermatitis
Psoriasis
Normal
0.74±0.17 1.2±0.39 5.95±0.66
Atopic
dermatitis
Psoriasis
0
1
2
3
4
5
0
1
2
3
0
0
2
4
8
8
1
2
3
4
5
Figure 1. Real time RT-PCR reveals the selected clones from the SSH library. The total RNA was isolated
from 14 different skin biopsy samples from AD patients, 10 samples from psoriasis patients, and 10
samples from normal controls. Each bar shows the relative gene expressions of the target genes compared
to the expression of the b-actin gene. The results are means7SEM.
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were chosen for validation. Intense
pruritus is another major feature of
AD. The pathogenesis of cutaneous
pruritus is not well understood, but
it is thought to be induced by the
various products from the inflammatory
effector cells, including neuropeptides,
histamine, leukotrienes, and proteolytic
enzymes. The prolyl endopeptidase and
cathepsin B might be genes responsible
for producing the inflammatory agents.
Finally, coxsackie virus and adenovirus
receptor and delta sleep inducing pep-
tide are genes that were found repeat-
edly in the SSH library and their
expression levels were confirmed. Five
genes showed increased expression
levels in the AD samples compared
to normal control samples (Figure 1).
The coxsackie virus and adenovirus
receptor, prolyl endopeptidase, delta
sleep inducing peptide, and sphingo-
sine-1-phosphate lyase genes showed
markedly increased expression levels
in the AD samples compared to the
normal and psoriasis samples, but
their expression levels in the psoriasis
samples were lower than in the normal
control samples. CTBS was the only
gene that had a greater expression in
the psoriasis samples than in the AD
and normal samples (Figure 1).
In conclusion, this study was the
first attempt to identify differentially
expressed genes in lesional AD skin to
help increase our understanding of AD
with its complicated disease mechan-
ism. Although the known and unknown
genes found by using the SSH method
may be helpful in understanding the
complicated atopic pathophysiology,
there is a drawback that we used only
one normal sample. However, among
the 5 genes that were examined at the
transcription level, sphingosine-1-phos-
phate lyase, coxsackie virus and ade-
novirus receptor, prolyl endopeptidase,
and delta sleep inducing peptide are
genes that have not yet been studied for
the other skin diseases as well as AD.
Therefore, besides the known factors,
these genes are thought to provide an
important clue in analyzing the com-
plex mechanism of dry skin and itching.
In recent years, single-nucleotide poly-
morphism studies have made active
progress to grasp the individual genetic
causes of AD. However, most of the
studies focused on the known genes.
Thus, we adopted several tools to cover
as many genes as possible and comple-
ment the significance of the selected
genes with the SSH method. We are
currently in progress on an SNP study
centering on the genes included in the
SSH library. We hope that the selected
genes can be used for the treatment and
diagnosis of this common allergic skin
disease.
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TO THE EDITOR
Cutaneous T-cell-attracting chemokine
(CTACK), also called CCL27, belongs to
the CC chemokine family and is a ligand
for CC chemokine receptor (CCR) 10. It is
selectively and constitutively produced in
skin by epidermal keratinocytes (Morales
et al., 1999) and displayed on the surface
of dermal endothelial cells (Homey et al.,
2002). It selectively attracts cutaneous
lymphocyte antigen positive, CCR10-
positive memory T cells into inflamma-
tory sites (Morales et al., 1999). We and
other researchers previously reported that
serum levels of this chemokine reflect
disease activity of atopic dermatitis
(Kakinuma et al., 2003a; Hijnen et al.,
2004; Hon et al., 2004).
Abbreviations: CCR, CC chemokine receptor; CTACK, cutaneous T-cell-attracting chemokine;
CTCL, cutaneous T-cell lymphoma; MF, mycosis fungoides; TBI, tumor burden index
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CTACK/CCL 27 in CTCL
